Molbio Diagnostics Ltd (MOLBIO) — Board Meeting | 25 September 2026
Molbio Diagnostics announced the re-appointment of K.S. Kamalakara & Co as cost auditor for FY 2026-27 following a board meeting on September 25, 2026, confirming the firm's continued role in cost account audits.
About Molbio Diagnostics Ltd (MOLBIO)
Healthcare · Healthcare · Listed on BSE
📡 Get AI alerts when MOLBIO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track MOLBIO — Free💡 Ask AI about this filing
📊 More MOLBIO filings
- 🔴 Insider Trading — 1 October 2026Molbio Diagnostics disclosed a shareholding update from India Business Excellence Fund III under SEB...
- Announcement — 28 September 2026Molbio Diagnostics Ltd announced that its trading window will close on October 1, 2026, for insiders...
- 🔴 Announcement — 17 September 2026Molbio Diagnostics announced a virtual investor meeting on September 22, 2026 at 11:00 AM IST to dis...
- 🔴 Financial Results — 12 September 2026Molbio Diagnostics reported Q1 FY27 revenue of [amount context mismatch] crores with 25% EBITDA marg...
- Announcement — 9 September 2026Molbio Diagnostics Ltd announced a change to its Corporate Identification Number (CIN) from U33125GA...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when MOLBIO files new disclosures
Track MOLBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MOLBIO — FreeFree account · 2 AI queries/day